GlassScriptPhysician profile
Gurtej Singh
NPI 1255852422
$1,759.55
in general payments reported to CMS, 2019-2025
7 companies · $968 in 2025
The $968 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $141 · 2022: $119 · 2023: $397 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $795 · Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $794.97 |
| Food and Beverage | $570.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $950.15 | 2023-2025 | Reactiv8 |
| Nevro Corp. | $217.28 | 2023 | Senza |
| Globus Medical, INC. | $173.00 | 2025 | Senza |
| Ucb, INC. | $123.28 | 2022-2023 | Briviact |
| Genzyme Corporation | $119.90 | 2019-2020 | |
| Biogen, INC. | $97.91 | 2020-2022 | |
| Emd Serono, INC. | $78.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurtej Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.